Indefinite Delivery Contract 75N94020D00005

Award Date 8/1/20
Last Date to Order 7/31/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health's National Institute of Child Health and Human Development awarded Emory University multiple contracts to support its Contraceptive Development Program. Under an indefinite delivery contract with a potential value of $5 million, Emory will conduct clinical trials of contraceptive products and treatments for gynecologic conditions from 2020-2027 on a task order basis. Two task orders were issued, the first for $94,652 to finalize the protocol and commence patient...
The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to the University of Utah Office of Sponsored Projects Division to conduct clinical trials in support of contraceptive development. The multiple award IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, the prime contractor will receive task orders to finalize protocols, obtain regulatory approvals, and commence...
The National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services, awarded a $5,000,000 Indefinite Delivery Contract (IDC) to The Regents of the University of Colorado to conduct clinical trials for new contraceptive methods and treatments for gynecological conditions over a 7-year period ending in 2027. This IDC is part of NICHD's Contraceptive Development Program and Contraceptive Clinical Trials Network (CCTN), which aims to advance...
The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to The Regents of the University of California, San Francisco to conduct clinical trials in support of contraceptive development. With a potential value of $5 million and a period of performance through July 2027, this multiple-award contract enables the agency to issue task orders for phase I-IV contraceptive trials in women and treatment trials for gynecologic...
The National Institutes of Health National Institute of Child Health and Human Development awarded an indefinite delivery contract to Essential Access Health to conduct clinical trials and develop protocols in support of the Contraceptive Development Program. The IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, Essential Access Health has received two cost-no-fee delivery orders to date. The first, valued at $349,327, tasks the contractor to...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a multiple award indefinite delivery contract to the University of Hawaii at Manoa to support the agency's Contraceptive Development Program and Contraceptive Clinical Trials Network. The contract has a potential value of $5 million and period of performance through July 2027. Two delivery orders have been awarded against the contract to date. The first is a $64k order for protocol finalization...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, has awarded a $5,000,000 Indefinite Delivery Contract (IDC) to The Trustees of Columbia University in the City of New York to conduct Phase I, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order basis. This multiple award IDC has an...
The National Institutes of Health National Institute of Child Health and Human Development awarded a multiple award indefinite delivery contract to The Johns Hopkins University to conduct clinical research in support of contraceptive development and trials. With a potential value of $5,000,000 over a period from August 2020 through July 2027, the IDV enables task orders for protocol review, development assistance, and activities associated with the Contraceptive Clinical Trials Network...
The National Institutes of Health's National Institute of Child Health and Human Development awarded multiple indefinite delivery contracts to establish the Contraceptive Clinical Trials Network for female clinical research sites. Magee-Womens Research Institute and Foundation was awarded contracts under this vehicle to conduct various clinical trials. Two delivery orders were issued to Magee-Womens Research Institute and Foundation under the Network's contracts. The first was for...
The National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDV) valued at $5,000,000 to the University of Cincinnati's Sponsored Research Services Division. This 7-year IDV facilitates the conduct of clinical trials related to contraceptive development, gynecologic conditions, and associated protocol development. Under this IDV, two task orders have been issued to the University of...
  • 75N94020D00005
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract has a potential value of $5,000,000 and period of performance through July 2027. Task orders issued to date include $92,034 for finalizing a clinical trial protocol and $103,767 to assist in developing new contraceptive products through activities such as protocol review and development associated with the Contraceptive Clinical Trials Network program.

The original solicitation sought capability statements from organizations to conduct Phase I-IV contraceptive clinical trials for women, as well as trials for conditions like endometriosis under the National Institute of Child Health and Human Development's Contraceptive Development Program. Respondents were required to demonstrate experience in areas like managing clinical trials, recruiting and retaining subjects, conducting pharmacokinetic studies, and evaluating surrogate markers for contraceptive effectiveness using techniques such as transvaginal ultrasound. The purpose of the program and resultant contract is to develop new contraceptive methods and advance candidate products through the regulatory process towards approval by the U.S. Food and Drug Administration.

Generated 1/5/24, 1:26 AM